Page last updated: 2024-08-24

cephalosporin c and hydroxychloroquine

cephalosporin c has been researched along with hydroxychloroquine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (100.00)	2.80

Authors

Authors	Studies
Benoit, JL; Farley, B; Frohne, C; Hazra, A; McNulty, M; Pettit, N; Pho, M; Pitrak, D; Pursell, K; Ridgway, JP; Saltzman, J; Schmitt, J; Uvin, AZ	1
Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S	1
Buttazzi, R; Di Mario, S; Gagliotti, C; Moro, ML; Ricchizzi, E; Tedeschi, S	1
Hong, W; Hwang, TH; Jang, J; Jang, SP; Jang, SW; Kim, BO; Park, HW; Park, SK; Park, YK; Shin, J; Yang, W	1

Trials

1 trial(s) available for cephalosporin c and hydroxychloroquine

Article	Year
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4 Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome	2020

Article

Year

RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.

The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4

Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome

2020

Other Studies

3 other study(ies) available for cephalosporin c and hydroxychloroquine

Article	Year
A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois. AIDS patient care and STDs, 2020, Volume: 34, Issue:8 Topics: Adult; Antiretroviral Therapy, Highly Active; Azithromycin; Betacoronavirus; CD4 Lymphocyte Count; Cephalosporins; Chicago; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; HIV Infections; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Serologic Tests; Treatment Outcome	2020
Community use of antibiotics during the COVID-19 lockdown. Infectious diseases (London, England), 2021, Volume: 53, Issue:2 Topics: Adenoviridae; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Cephalosporins; COVID-19; COVID-19 Drug Treatment; Fluoroquinolones; Humans; Hydroxychloroquine; Incidence; Influenza A virus; Influenza B virus; Influenza, Human; Italy; Macrolides; Pandemics; Penicillins; Physical Distancing; Prescription Drug Overuse; Quarantine; Respiratory Syncytial Viruses; Respiratory Tract Infections; SARS-CoV-2	2021
Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study. PloS one, 2022, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Cephalosporins; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Lopinavir; Retrospective Studies; Ritonavir; SARS-CoV-2; Treatment Outcome	2022